Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin
April 26, 2024 07:10 ET
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Global Penicillin Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The penicillin market is forecasted to grow by USD...
Global Antibiotics Market Analysis Report 2024-2030: Penicillin Drug Class Segment Led the Market in 2023, the Cephalosporin Segment is Anticipated to Register the Fastest CAGR from 2024 to 2030
April 26, 2024 04:05 ET
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Global Antibiotics Market Size, Share & Trends Analysis Report by Action Mechanism (Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors),...
Norfloxacin (CAS 70458-96-7) Global Market Research Report 2024
April 22, 2024 10:01 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Norfloxacin (CAS 70458-96-7) Global Market Research Report 2024" report has been added to ResearchAndMarkets.com's offering. This global report...
Europe Antibiotics (Cephalosporin, Penicillin) Market Trends Analysis Report 2024-2030: Generic Antibiotics Dominate Supported by Regulatory Framework, Branded Antibiotics to Witness Rapid Growth
April 11, 2024 11:19 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Europe Antibiotics Market Size, Share & Trends Analysis Report by Drug Class (Cephalosporin, Penicillin), Type (Branded Antibodies, Generic...
Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain
March 07, 2024 03:00 ET
|
Persica Pharmaceuticals
Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain London, UK, 07 March 2024 – Persica Pharmaceuticals Ltd, a privately held,...
Paratek Pharmaceuticals Announces Positive Efficacy Data for NUZYRA® as Post-Exposure Prophylaxis of Inhalational Anthrax, Triggering Additional Procurement under BARDA Project BioShield Contract
March 05, 2024 06:45 ET
|
Paratek Pharmaceuticals, Inc.
Paratek Announces Positive Efficacy Data for NUZYRA®, Triggering Additional Procurement under BARDA Project BioShield Contract
Biopharmaceutical Fermentation Systems Market Projected to Reach USD 52.6 billion by 2031, with a CAGR of 9.5%: Report by Transparency Market Research Inc.
March 01, 2024 01:32 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 01, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global biopharmaceutical fermentation systems market is projected to grow at a CAGR of...
Chronic Obstructive Pulmonary Disease Treatment Market revenue to cross USD 22 Billion by 2036, says Research Nester
February 29, 2024 07:30 ET
|
Research Nester
New York, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The global chronic obstructive pulmonary disease (COPD) treatment market size is estimated to attain at ~9% CAGR from 2024 to 2036. The market is expected...
Daptomycin Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Teva Pharma, Merck, Cipla, Pfizer, BE Pharmaceuticals, Reddy's Laboratories, and Mylan
February 20, 2024 09:57 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Daptomycin Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6
February 20, 2024 04:00 ET
|
AKAMPION
- Designation underlines the need for novel, first-in-class antimicrobials for the treatment of infections with Gram-negative bacteria JERUSALEM, Israel, February 20, 2023 -- Omnix Medical, a...